What Next for Protagonist Therapeutics Inc (NASDAQ:PTGX) Stock After Increase in Shorted Shares?

August 10, 2018 - By Jeanette Kaplan

The stock of Protagonist Therapeutics Inc (NASDAQ:PTGX) registered an increase of 13.12% in short interest. PTGX’s total short interest was 217,200 shares in August as published by FINRA. Its up 13.12% from 192,000 shares, reported previously. With 111,600 shares average volume, it will take short sellers 2 days to cover their PTGX’s short positions. The short interest to Protagonist Therapeutics Inc’s float is 1.94%.

The stock decreased 7.55% or $0.85 during the last trading session, reaching $10.41. About 283,399 shares traded. Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has declined 22.47% since August 10, 2017 and is downtrending. It has underperformed by 35.04% the S&P500.

Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide chemical entities to address various unmet medical needs. The company has market cap of $220.73 million. It primarily focuses on developing oral peptide drugs. It currently has negative earnings. The companyÂ’s lead product candidates include PTG-100, an oral alpha-4-beta-7 integrin-specific antagonist that is in phase II clinical trial for the treatment of inflammatory bowel disease ; and PTG-200, an interleukin-23 receptor specific antagonist, which is under pre-clinical development stage for the treatment of IBD.

More notable recent Protagonist Therapeutics, Inc. (NASDAQ:PTGX) news were published by: Benzinga.com which released: “36 Stocks Moving In Tuesday’s Pre-Market Session” on August 07, 2018, also Streetinsider.com with their article: “Protagonist Therapeutics (PTGX) Enters Securities Purchase Agreement for Up 2.75M Shares” published on August 07, 2018, Benzinga.com published: “44 Stocks Moving In Monday’s Mid-Day Session” on August 06, 2018. More interesting news about Protagonist Therapeutics, Inc. (NASDAQ:PTGX) were released by: Gurufocus.com and their article: “Factors of Influence in 2018, Key Indicators and Opportunity within Protagonist Therapeutics, HD Supply, BIOHAVEN …” published on August 01, 2018 as well as Benzinga.com‘s news article titled: “52 Biggest Movers From Yesterday” with publication date: August 07, 2018.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: